Patents by Inventor Chérif Rabhi

Chérif Rabhi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for treating neurodegenerative disorders
    Patent number: 11634452
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: April 25, 2023
    Assignees: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • Method for obtaining a plant extract and associated compositions
    Patent number: 11129864
    Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: September 28, 2021
    Assignees: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouazzani, Guillaume Arcile
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210087222
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 25, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210079035
    Abstract: Compounds for treating neurodegenerative disorders The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 18, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210070799
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 11, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • Use of a extract for the treatment of amyloid-related diseases
    Patent number: 10596216
    Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: March 24, 2020
    Assignee: Ethnodyne and Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouazzani, Guillaume Arcile
  • Compositions containing a extract incubated with a filamentous fungus of the genus
    Patent number: 10596217
    Abstract: The invention relates to a composition containing a Withania somnifera extract, obtained by fermentation by incubating the Withania somnifera extract with a filamentous fungus of the Beauveria genus. The composition can be used to treat or prevent ?-synucleinopathies in a subject.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: March 24, 2020
    Assignees: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouazzani, Guillaume Arcile
  • METHOD FOR OBTAINING A PLANT EXTRACT AND ASSOCIATED COMPOSITIONS
    Publication number: 20180289761
    Abstract: The invention relates to a tablet or capsule containing a plant extract, to assist in the treatment or prevention of disorders or diseases. The tablet or capsule includes bioconverted products provided by fermenting Withania Somnifera extract, Emblica officinalis extract, and Bacopa monnieri extract.
    Type: Application
    Filed: May 21, 2018
    Publication date: October 11, 2018
    Applicants: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouazzani, Guillaume Arcile
  • Method for obtaining a plant extract and associated compositions
    Patent number: 9999647
    Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: June 19, 2018
    Assignees: Ethnodyne, Centre National De La Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouanzzani, Guillaume Arcile
  • USE OF A WITHANIA EXTRACT FOR THE TREATMENT OF ALPHA SYNUCLEINOPATHIES
    Publication number: 20180110820
    Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to prevent, treat of delay the progression of ?-synuclemopathies, including Parkinson disease.
    Type: Application
    Filed: April 13, 2015
    Publication date: April 26, 2018
    Applicants: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouanzzani, Guillaume Arcile
  • USE OF A WITHANIA EXTRACT FOR THE TREATMENT OF AMYLOID-RELATED DISEASES
    Publication number: 20180042979
    Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.
    Type: Application
    Filed: March 23, 2015
    Publication date: February 15, 2018
    Applicants: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouanzzani, Guillaume Arcile
  • METHOD FOR OBTAINING A PLANT EXTRACT AND ASSOCIATED COMPOSITIONS
    Publication number: 20160101142
    Abstract: The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Applicants: Ethnodyne, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Jamal Ouanzzani, Guillaume Arcile
  • 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
    Patent number: 7339061
    Abstract: Compound of formula (I): wherein: R1, R2, R3, R4, R6, R8, R9 and R10, which may be the same or different, each represent a group selected from hydrogen, hydroxy, alkoxy, alkyl, arylalkoxy, alkoxycarbonylalkoxy and OR? wherein R? represents an ionised or ionisable group, R5 represents a group selected from alkyl, aryl and heteroaryl, R7 represents a group selected from hydrogen, hydroxy, alkoxy, alkyl and cycloalkyl, or R7 represents a nitrogen-containing or oxygen-containing heterocycle, its optical isomers, hydrates and solvates thereof and addition salts thereof, with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti-cancer agents.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: March 4, 2008
    Assignee: Les Laboratoires Servier
    Inventors: Jean-Daniel Brion, Lucien Israel, Alain Le Ridant, Catherine Harpey, Cherif Rabhi, El Bachir Kaloun
  • Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent
    Publication number: 20060135618
    Abstract: The invention concerns a medicine or a cosmetic composition comprising at least one thiourea of general formula (I), or at least one of its monooxide or dioxide derivatives of general formulae (IIa), (IIb) and (III), or mixtures thereof. This medicine is advantageously used for inhibiting tyrosinase, inhibiting melanin synthesis, for lightening or depigmenting the skin or for eliminating age spots and as antimutagenic and anti-carcinogenic agent.
    Type: Application
    Filed: October 3, 2003
    Publication date: June 22, 2006
    Inventors: Daniel Jean, Cherif Rabhi, Veronique Schwaab
  • Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
    Publication number: 20060063801
    Abstract: Compound of formula (I): wherein: R1, R2, R3, R4, R6, R8, R9 and R10, which may be the same or different, each represent a group selected from hydrogen, hydroxy, alkoxy, alkyl, arylalkoxy, alkoxycarbonylalkoxy and OR? wherein R? represents an ionised or ionisable group, R5 represents a group selected from alkyl, aryl and heteroaryl, R7 represents a group selected from hydrogen, hydroxy, alkoxy, alkyl and cycloalkyl, or R7 represents a nitrogen-containing or oxygen-containing heterocycle, its optical isomers, hydrates and solvates thereof and addition salts thereof, with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti-cancer agents.
    Type: Application
    Filed: June 18, 2003
    Publication date: March 23, 2006
    Inventors: Jean-Daniel Brion, Lucien Israel, Alain Le Ridant, Catherine Harpey, Cherif Rabhi, El Bachir Kaloun